...
机译:切换到Maraviroc Plus Darunavir / Ritonavir双重治疗在病毒学抑制患者对肝纤维化进展的影响:随机研究中的结果
Azienda Osped Univ Senese Infect Dis Unit Siena Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Azienda Osped Univ Careggi Clin Infect Dis Florence Italy;
Azienda Osped Univ S Orsola Malpighi Clin Infect Dis Bologna Italy;
IRCCS IFO Infect Dermatol &
Allergol Via Elio Chianesi Rome Italy;
IRCCS IFO Infect Dermatol &
Allergol Via Elio Chianesi Rome Italy;
Univ G dAnnunzio Clin Infect Dis Chieti Italy;
Univ Milan DIBIC L Sacco Hosp Infect &
Trop Dis Unit Milan Italy;
IRCCS S Martino IST Infect Dis Unit Genoa Italy;
Amedeo Savoia Hosp Infect Dis Unit A Turin Italy;
Sapienza Univ Rome Dept Translat &
Precis Med Rome Italy;
Sapienza Univ Rome Dept Publ Hlth &
Infect Dis Rome Italy;
Univ Perugia Clin Infect Dis Perugia Italy;
Sapienza Univ Dept Publ Hlth &
Infect Dis SM Goretti Hosp Infect Dis Unit Latina Italy;
Pistoia Hosp Infect Dis Unit Pistoia Italy;
Pesaro Hosp Infect Dis Unit Pesaro Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Univ Milan San Paolo Hosp Dept Hlth Sci Infect &
Trop Dis Inst Milan Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Azienda Osped Univ Senese Infect Dis Unit Siena Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Univ Cattolica Sacro Cuore Clin Infect Dis Rome Italy;
Univ Cattolica Sacro Cuore Pharmacol Dept Rome Italy;
Univ Cattolica Sacro Cuore Pharmacol Dept Rome Italy;
Univ Cattolica Sacro Cuore Pharmacol Dept Rome Italy;
Univ Milan San Paolo Hosp Dept Hlth Sci Infect &
Trop Dis Inst Milan Italy;
Azienda Osped Univ Senese Infect Dis Unit Siena Italy;
Univ Siena Dept Med Biotechnol Siena Italy;
Univ Siena Dept Med Biotechnol Siena Italy;
Univ Perugia Clin Infect Dis Perugia Italy;
Univ Perugia Clin Infect Dis Perugia Italy;
Univ Perugia Clin Infect Dis Perugia Italy;
Univ G dAnnunzio Clin Infect Dis Chieti Italy;
Univ G dAnnunzio Clin Infect Dis Chieti Italy;
Univ G dAnnunzio Clin Infect Dis Chieti Italy;
Univ G dAnnunzio Clin Infect Dis Chieti Italy;
IRCCS S Martino IST Infect Dis Unit Genoa Italy;
IRCCS S Martino IST Infect Dis Unit Genoa Italy;
IRCCS S Martino IST Infect Dis Unit Genoa Italy;
IRCCS S Martino IST Infect Dis Unit Genoa Italy;
IRCCS S Martino IST Virol Genoa Italy;
Univ Milan DIBIC L Sacco Hosp Infect &
Trop Dis Unit Milan Italy;
Univ Milan DIBIC L Sacco Hosp Infect &
Trop Dis Unit Milan Italy;
Univ Milan DIBIC L Sacco Hosp Infect &
Trop Dis Unit Milan Italy;
L Sacco Hosp Vialba Microbiol &
Virol Lab Via GB Grassi Milan Italy;
IRCCS IFO Infect Dermatol &
Allergol Via Elio Chianesi Rome Italy;
IRCCS IFO Infect Dermatol &
Allergol Via Elio Chianesi Rome Italy;
IRCCS IFO Infect Dermatol &
Allergol Via Elio Chianesi Rome Italy;
Sapienza Univ Rome Dept Clin Med Rome Italy;
Sapienza Univ Rome Dept Publ Hlth &
Infect Dis Rome Italy;
Sapienza Univ Rome Dept Publ Hlth &
Infect Dis Rome Italy;
Sapienza Univ Rome Virol Rome Italy;
Sapienza Univ Rome Virol Rome Italy;
S Caterina Novella Hosp Div Infect Dis Lecce Italy;
Azienda Osped Univ S Orsola Malpighi Clin Infect Dis Bologna Italy;
Azienda Osped Univ S Orsola Malpighi Clin Infect Dis Bologna Italy;
Azienda Osped Univ S Orsola Malpighi Clin Infect Dis Bologna Italy;
Azienda Osped Univ S Orsola Malpighi Clin Infect Dis Bologna Italy;
Azienda Osped Univ S Orsola Malpighi Clin Infect Dis Bologna Italy;
Azienda Osped Univ S Orsola Malpighi Clin Infect Dis Bologna Italy;
Azienda Osped Univ S Orsola Malpighi Clin Infect Dis Bologna Italy;
Azienda Osped Univ S Orsola Malpighi Microbiol Bologna Italy;
Azienda Osped Univ S Orsola Malpighi Microbiol Bologna Italy;
Amedeo Savoia Hosp Infect Dis Unit A Turin Italy;
Amedeo Savoia Hosp Infect Dis Unit A Turin Italy;
Amedeo Savoia Hosp Infect Dis Unit A Turin Italy;
Amedeo Savoia Hosp Microbiol &
Virol Lab Turin Italy;
Pesaro Hosp Infect Dis Unit Pesaro Italy;
Pistoia Hosp Infect Dis Unit Pistoia Italy;
Sapienza Univ Dept Publ Hlth &
Infect Dis SM Goretti Hosp Infect Dis Unit Latina Italy;
Sapienza Univ Dept Publ Hlth &
Infect Dis SM Goretti Hosp Infect Dis Unit Latina Italy;
Azienda Osped Univ Careggi Clin Infect Dis Florence Italy;
Azienda Osped Univ Careggi Clin Infect Dis Florence Italy;
Azienda Osped Univ Careggi Clin Infect Dis Florence Italy;
Univ Milan San Paolo Hosp Dept Hlth Sci Infect &
Trop Dis Inst Milan Italy;
Univ Milan San Paolo Hosp Dept Hlth Sci Infect &
Trop Dis Inst Milan Italy;
IRCCS L Spallanzani Infect Dis Unit Rome Italy;
IRCCS L Spallanzani Infect Dis Unit Rome Italy;
IRCCS L Spallanzani Infect Dis Unit Rome Italy;
IRCCS L Spallanzani Infect Dis Unit Rome Italy;
IRCCS L Spallanzani Infect Dis Unit Rome Italy;
IRCCS L Spallanzani Infect Dis Unit Rome Italy;
Univ Roma Tor Vergata Dept Expt Med &
Surg Rome Italy;
Univ Roma Tor Vergata Dept Expt Med &
Surg Rome Italy;
机译:切换到Maraviroc Plus Darunavir / Ritonavir双重治疗在病毒学抑制患者对肝纤维化进展的影响:随机研究中的结果
机译:在病毒学抑制的病毒抑制患者中转换为Darunavir / CObicistat的有效性,接受Ritonavir-Boosted Protease抑制剂的基于植物的方案:“商店”研究
机译:在病毒学抑制的成年人中转向Dolututgravir的疗效和安全性与HIV-1的病毒学抑制剂:随机,开放标签,多中心,第3阶段,非流动性试验:双重研究
机译:以前艾滋病病毒抑制患者在替诺福韦加上基于Abacavir的病毒学结果(恢复研究)
机译:乙型肝炎病毒治疗患者体验,成功治疗对肝硬化的影响,以及持续的病毒性反应的含义
机译:病毒学抑制患者改用Maraviroc + Darunavir / Ritonavir双重疗法对肝纤维化进展的影响:一项随机研究的结果
机译:抑制HIV-1的患者在QD情况下改用darunavir / r均为QD的maraviroc耐受性良好,但在病毒学上不如标准抗逆转录病毒疗法:随机试验48周的结果